Pharmac updates

Pharmac is widening access to the Meningoccal B vaccine (Bexsero) to enable those who missed does in their first year of life to complete their vaccination course. From September 2025, all children under 5 years of age will be able to access the fully funded meningococcal B vaccine which was originally scheduled to end on 31 August 2025. Up to 77,000 children are anticipated to benefit from this change. Read the full decision on the Pharmac website .